[1]
Dong K,Song Y,Li X,Ding J,Gao Z,Lu D,Zhu Y, Pentasaccharides for the prevention of venous thromboembolism. The Cochrane database of systematic reviews. 2016 Oct 31 [PubMed PMID: 27797404]
[2]
Mulloy B,Hogwood J,Gray E,Lever R,Page CP, Pharmacology of Heparin and Related Drugs. Pharmacological reviews. 2016 Jan [PubMed PMID: 26672027]
[3]
Seaman S,Nelson A,Noble S, Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study. Patient preference and adherence. 2014 [PubMed PMID: 24748774]
[5]
Gajic-Veljanoski O,Phua CW,Shah PS,Cheung AM, Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis. Journal of general internal medicine. 2016 Aug [PubMed PMID: 26895998]
[6]
Levesque H,Verdier S,Cailleux N,Elie-Legrand MC,Gancel A,Basuyau JP,Borg JY,Moore N,Courtois H, Low molecular weight heparins and hypoaldosteronism. BMJ (Clinical research ed.). 1990 Jun 2 [PubMed PMID: 2165831]
[7]
Cesana P,Scherer K,Bircher AJ, Immediate Type Hypersensitivity to Heparins: Two Case Reports and a Review of the Literature. International archives of allergy and immunology. 2016 [PubMed PMID: 28049195]
[8]
Anderson FA Jr,Zayaruzny M,Heit JA,Fidan D,Cohen AT, Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. American journal of hematology. 2007 Sep [PubMed PMID: 17626254]
[9]
Guyatt GH,Akl EA,Crowther M,Gutterman DD,Schuünemann HJ, Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb [PubMed PMID: 22315257]
[10]
Horlander KT,Mannino DM,Leeper KV, Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Archives of internal medicine. 2003 Jul 28 [PubMed PMID: 12885687]
[11]
Mismetti P,Laporte S,Darmon JY,Buchmüller A,Decousus H, Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. The British journal of surgery. 2001 Jul [PubMed PMID: 11442521]
[12]
Treasure T,Hill J, NICE guidance on reducing the risk of venous thromboembolism in patients admitted to hospital. Journal of the Royal Society of Medicine. 2010 Jun [PubMed PMID: 20513894]
[13]
Barrera LM,Perel P,Ker K,Cirocchi R,Farinella E,Morales Uribe CH, Thromboprophylaxis for trauma patients. The Cochrane database of systematic reviews. 2013 Mar 28 [PubMed PMID: 23543562]
[15]
Rasmussen MS,Jørgensen LN,Wille-Jørgensen P, Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. The Cochrane database of systematic reviews. 2009 Jan 21 [PubMed PMID: 19160234]
[16]
Wille-Jørgensen P,Rasmussen MS,Andersen BR,Borly L, Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. The Cochrane database of systematic reviews. 2003 [PubMed PMID: 14583929]
[17]
Salazar CA,Malaga G,Malasquez G, Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. The Cochrane database of systematic reviews. 2010 Apr 14 [PubMed PMID: 20393944]
[18]
Streiff MB,Carolan HT,Hobson DB,Kraus PS,Holzmueller CG,Demski R,Lau BD,Biscup-Horn P,Pronovost PJ,Haut ER, Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ (Clinical research ed.). 2012 Jun 19 [PubMed PMID: 22718994]
[19]
Rohailla S,Malinowski AK,Gandhi S,McLeod A,Nisenbaum R,Shehata N, The Approach to Peripartum Management of Anticoagulation: A Multidisciplinary Survey. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2018 Jul [PubMed PMID: 29709455]
[20]
Matar CF,Kahale LA,Hakoum MB,Tsolakian IG,Etxeandia-Ikobaltzeta I,Yosuico VE,Terrenato I,Sperati F,Barba M,Schünemann H,Akl EA, Anticoagulation for perioperative thromboprophylaxis in people with cancer. The Cochrane database of systematic reviews. 2018 Jul 11 [PubMed PMID: 29993117]
[21]
Farge D,Cajfinger F,Falvo N,Berremili T,Couturaud F,Bensaoula O,Védrine L,Bensalha H,Bonnet I,Péré-Vergé D,Coudurier M,Li V,Rafii H,Benzidia I,Connors JM,Resche-Rigon M, Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). Oncotarget. 2018 Jun 5 [PubMed PMID: 29930745]